Aldosterone receptors and the evaluation of plasma mineralocorticoid activity in normal and hypertensive states.
Open Access
- 1 September 1976
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 58 (3) , 579-589
- https://doi.org/10.1172/jci108504
Abstract
Aldosterone receptors from rat kidney slices were utilized in a competitive binding technique to analyze the contribution of various steroids to plasma "mineralocorticoid" activity and to assess their possible role in hypertension. To consider simultaneously the plasma binding, steroids were incubated with slices in undiluted plasma; competitor activities for [3H]aldosterone binding were aldosterone, 100%; deoxycorticosterone, 16.2%; cortisol, 0.4%; and 18-hydroxy-deoxy-corticosterone and d18-hydroxy-corticosterone, 0.1%. These steroids were more active in buffer than plasma, suggesting that they bind to plasma and that this reduces their receptor binding. Analysis of the competition data suggests that at normal plasma concentrations, aldosterone occupies the receptors to a major extent, cortisol occupies some of the receptors, and deoxycorticosterone and 8-hydroxydeoxycorticosterone contribute little to receptor occupancy. Two steroids implicated in low-renin essential hypertension, 16beta-hydroxy-dehydro-epiandrosterone and 16-oxoandrostenediol, did not have significant competitor activity. Competitor activity in plasmas from normal subjects taken at 12 noon (upright) was greater than that in those taken at 8 a.m. (supine). Since the 12 noon samples had higher aldosterone and lower cortisol levels than the 8 a.m. samples, the competitor activity under these physiological circumstances reflects aldosterone more than cortisol. The competitor activities of plasmas from patients relative to normal subjects (100+/-12.1%; mean+/-SEM) were: normal renin "essential" hypertension, 117+/-14%; low-renin essential hypertension, 101+/-6.6%; and primary aldosteronism, 176+/-14.3%. Thus a significant increase in activity of steroids that interact with mineralocorticoid receptors was detected in primary aldosteronism (P LESS THAN 0.01) BUT WAS NOT DETECTED IN LOW-RENIN OR NORMAL-RENIN ESSENTIAL HYPERTENSION.This publication has 42 references indexed in Scilit:
- Adrenal steroidogenesis in “low renin” or hyporeninemic hypertensionJournal of Steroid Biochemistry, 1975
- BODY-FLUID VOLUME IN LOW-RENIN HYPERTENSIONThe Lancet, 1974
- SODIUM AND THE RENIN-ANGIOTENSIN SYSTEM IN ESSENTIAL HYPERTENSION AND MINERALOCORTICOID EXCESSThe Lancet, 1974
- Volume factor in low and normal renin essential hypertension: Treatment with either spironolactone or chlorthalidoneThe American Journal of Cardiology, 1973
- Glucocorticoid receptors: Relations between steroid binding and biological effectsJournal of Molecular Biology, 1972
- RENAL-VEIN RENIN IN VARIOUS FORMS OF RENAL HYPERTENSIONThe Lancet, 1972
- Glucocorticoid and mineralocorticoid receptors for aldosteroneJournal of Steroid Biochemistry, 1972
- Mineralocorticoid production in hyperadrenocorticism: Role in pathogenesis of hypokalemic alkalosisThe American Journal of Medicine, 1971
- Effect of Spironolactone in Hypertensive PatientsThe Lancet Healthy Longevity, 1970
- Incidence of primary aldosteronism uncomplicated "essential" hypertension. A prospective study with elevated aldosterone secretion and suppressed plasma renin activity used as diagnostic criteriaPublished by American Medical Association (AMA) ,1968